Barium Sulfate Suspension Suppliers & Bulk Manufacturers
Available Forms: Powder for oral suspension
Available Strengths: 30% w/v , 40% w/v
Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)
Category:
Contrast Agent
Barium sulfate suspensions enhance X-ray and fluoroscopic imaging by coating the gastrointestinal tract, increasing tissue radiopacity. It provides detailed visualization of the esophagus, stomach, and intestines, aiding accurate diagnosis. Benefits include high image quality, rapid procedure, safety, and effective visualization of GI abnormalities worldwide.
Barium Sulfate Suspension is available in Powder for oral suspension
and strengths such as 30% w/v , 40% w/v.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Barium Sulfate Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Barium Sulfate Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Barium sulfate suspensions, marketed as Gastroview and Osmo-Maq in the US and EU, are approved for gastrointestinal imaging procedures. Regulatory approval requires detailed dossiers, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with safety and manufacturing standards across Europe. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, enabling accurate GI tract imaging for diagnosis and treatment planning worldwide, thus improving patient care across healthcare regions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing